INSULET INTERNATIONAL LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

UK-adopted International Accounting Standards

Reporting scope

Standalone (parent only)

Auditor

RSM UK Audit LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“After making enquiries, the directors have a reasonable expectation that the company has access to adequate resources to continue in operational existence and meet its liabilities as they fall due for the foreseeable future, being a period of at least 12 months from the date these financial statements were approved. Accordingly the directors continue to adopt the going concern basis for the preparation of the financial statements.”

Group structure

1. INSULET INTERNATIONAL LIMITED · parent
   1. Insulet Mexico, S. DE R.L. DE C.V. 99% · Mexico · Research and development
   2. Insulet Mexico Investments LLC 100% · United States · Holding company
   3. Insulet Asia (Singapore) Pte. Ltd. 100% · Singapore · Holding company
   4. Insulet Malaysia SDN. BHD. 100% · Singapore · Manufacture of medical devices

Significant events

• “In December 2023, we completed construction of our new manufacturing plant in Malaysia and, in 2024, we began producing sellable product at this manufacturing plant.”
• “On 31 March 2021, the company entered into a Platform Contribution License Agreement with Insulet Corporation under which it acquired the exclusive rights outside the US to the Business Intellectual Property in Omnipod 5 for consideration of GBP 29 million. The asset was placed in use during 2023.”
• “In 2024, the UK business delivered strong and sustained growth, building on the successful launch of Omnipod 5 in Q2 2023. The full-year impact of this rollout, combined with additional sensor integration with FreeStyle Libre 2+, further enhanced the offering and drove substantial expansion in New Customer Starts (NCS), well ahead of prior-year levels.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

8

last 12 months

Capital events

7

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +61.9%

  £95,319,188 → £154,278,791

• Cash

  +38.2%

  £16,824,276 → £23,251,884

• Net assets

  +87.5%

  £119,446,488 → £223,996,849

• Employees

  +19%

  147 → 175

• Operating profit

  +379.3%

  £6,241,173 → £29,915,576

• Profit before tax

  +478.4%

  £4,931,595 → £28,525,171

• Wages

  +16.9%

  £14,182,025 → £16,582,950

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers